BIOCOM Board of Directors

Chair:

Greg Lucier, Invitrogen Corp.

Vice Chair:

M. Wainwright Fishburn, Jr., Cooley Godward Kronish LLP

Chair Elect:

Randall E. Woods, Sequel Pharmaceuticals

Emeritus:

Paul Laikind, Ph.D., 

Vice President and General Counsel:

Stephen Ferruolo, J.D., Ph.D., Goodwin Procter LLP

Vice President – Finance:

Theresa Drew, Deloitte

Vice President and Secretary:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects

Vice President – Industry:

Dan Bradbury, Amylin Pharmaceuticals

President and CEO:

Joseph D. Panetta, BIOCOM

Life Director:

David Hale, Somaxon Pharmaceuticals

Life Director:

William Rastetter, Venrock Associates

Jack Lief, Arena Pharmaceuticals, Inc.
David Marino, Irving Hughes
Steven J. Mento, Ph.D., Conatus Pharmaceuticals, Inc.
Tina Nova, Genoptix
Trindl Reeves, Barney & Barney LLC
Larry Stambaugh, Apercu Consulting
Kleanthis G. Xanthopoulos, Ph.D., Regulus Therapeutics

Life Sciences Industry Sector:

Vince Anido, Ph.D., ISTA Pharmaceuticals
Rex Bright, SkinMedica, Inc.
Terrance J. Bruggeman, Geneve Bio, Inc.
Daniel Burgess, Mpex Pharmaceuticals, Inc.
Stephen M. Chang, Ph.D., Stemgent, Inc.
John M. Dunn, Biogen Idec, Inc .
Steven B. Engle, Xoma LLC
Gary Harbour, Ph.D., Genentech
Carl Hull, Gen-Probe, Inc.
John Hurrell, Ph.D., Focus Diagnostics
Alan Lewis, Ph.D., Novocell, Inc.
Alexis Lukianov, NuVasive, Inc.
Catherine Mackey, Ph.D., Pfizer La Jolla
Stuart Mackey, Amgen Ventures
Magda Marquet, Ph.D., Althea Technologies
Scott Salka, Ambit Biosciences
James Schaeffer, Ph.D., Merck Research Laboratories
Jackson Streeter, M.D., PhotoThera, Inc.
David Webb, Ph.D., Celgene
Gerald Yakatan, Ph.D., IriSys

Associate and Academic Members Sector:

Susan Bryant, Ph.D., UC Irvine
Carin Canale, Porter Novelli Life Sciences
Constance Carroll, Ph.D., San Diego Community College District
Larry Cohn, Stradling Yocca Carlson & Rauth
Scott Foote, Square 1 Bank
Milton Gordon, Ph.D., California State University, Fullerton
Jeffrey W. Guise, Ph.D., Wilson, Sonsini, Goodrich & Rosati
Lisa A. Haile, J.D., Ph.D., DLA Piper
Guy J. Iannuzzi, Mentus, Inc.
Brent D. Jacobs, Cushman & Wakefield
Richard Kaufman, Foley & Lardner LLP
Daniel Kleeburg, Ernst & Young
Mary E. Lyons, Ph.D., University of San Diego
Susan Nowakowski, AMN Healthcare Services
Elliot Parks, Ph.D., Hamilton BioVentures
John C. Reed, M.D., Ph.D., Burnham Institute for Medical Research
Theodore D. Roth, Roth Capital Partners LLC
Drew Senyei, M.D., Enterprise Partners Venture Capital
Bob Sullivan, Ph.D., UCSD Rady School of Management
Stephen Weber, Ph.D., San Diego State University
Kenneth J. Widder, M.D., Latterell Venture Partners
Scott N. Wolfe, Latham & Watkins LLP

BIOCOM Board Members-Ex-Officio:

Gary Friedman, Esq., The Agouron Institute
Julie Meier Wright, San Diego Regional EDC
Peter Preuss, The Preuss Foundation
Duane J. Roth, CONNECT